Frequently Asked Questions

Yes, all client information is protected under the Health Insurance Portability and Accountability Act (HIPAA). HIPAA is a US law designed to provide privacy standards to protect patients’ medical records and other health information provided to health plans, doctors, hospitals and other health care providers.

In the context of substance use disorder treatment, abstinence based treatment is behavioral therapy and the complete cessation of substance use. Medication-assisted treatment (MAT), including the office-based opioid treatment (OBOT) offered at SaVida Health, combines behavioral therapy and FDA-approved medications to treat substance use disorders. There is substantial evidence backing this approach for the treatment of opioid use disorder.

https://www.samhsa.gov/medication-assisted-treatment
https://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2016/11/medication-assisted-treatment-improves-outcomes-for-patients-with-opioid-use-disorder

There is substantial evidence supporting the use of medication assisted treatment (MAT) for opioid use disorder. MAT been shown to substantially reduce the mortality rate among those suffering from opioid use disorders. Patients in MAT are also more successful at staying in treatment versus abstinence-based approaches. However, you should contact a clinical professional before starting any form of treatment. The clinicians at SaVida Health are ready to help. Make an appointment today.

https://www.bmj.com/content/357/bmj.j1550
https://www.ncbi.nlm.nih.gov/pubmed/12606177

No, SaVida Health will work with you to find that combination of counseling, social services and medication that works for you.

Both buprenorphine-naltrexone and methadone are prescription medicines used to treat adults who are addicted to (dependent on) opioid drugs (either prescription or illegal) as part of a complete treatment program that also includes counseling and behavioral therapy. Unlike methadone treatment, which must be performed in a highly structured clinic with daily dosing, buprenorphine-naltrexone (brand names: Suboxone, Zubsolv, Bunavail) is the first medication to treat opioid dependency that is permitted to be prescribed or dispensed in physician offices, significantly increasing treatment access and allowing clients the convenience of less frequent visits to the treatment center or clinic. It also has unique pharmacological properties that help lower the potential for abuse and increase safety in cases of overdose. However buprenorphine-naltrexone is not right for everyone, and some will find methadone treatment supports their recovery better. Make an appointment with a SaVida Health today to find out if buprenorphine-naltrexone treatment is right for you.
Naltrexone can also be taken independently of buprenorphine. Naltrexone (brand name Vivitrol) is a non-addictive opioid antagonist that blocks the effects of other narcotics. Naltrexone binds and blocks opioid receptors, and is reported to reduce opioid cravings. Patients are warned to abstain from illegal opioids and opioid medication for a minimum of 7-10 days before starting naltrexone. If patients who are treated with naltrexone relapse after a period of abstinence, it is possible that the dosage of opioid that was previously used may have life-threatening consequences.
When used as a treatment for alcohol dependency, naltrexone blocks the euphoric effects and feelings of intoxication. This allows people with alcohol addiction to reduce their drinking behaviors enough to remain motivated to stay in treatment and avoid relapses. Naltrexone is not addictive nor does it react adversely with alcohol.
Make an appointment with a SaVida Health today to find out if buprenorphine or naltrexone treatment is right for you.

Additoinal Information:

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, place… – PubMed – NCBI

No, unlike methadone treatment, treatment with buprenorphine or naltrexone does not require daily visits to a clinic. Our clinicians will determine a prescription duration that is deemed clinically appropriate and responsible for each patient.

We accept Medicaid, Medicare and most insurances. If you are not currently insured, SaVida Health will work with you to find the best financial solution.

Yes, counseling and behavioral therapy are important components of the recovery process. SaVida Health believes in treating the whole person. While medication alone may reduce cravings, it alone is not a wholistic treatment.

SaVida Health’s case managers are counselors and social workers who assist our clients with removing the barriers to their recovery. Our case managers will work with you to identify and take advantage of child care, housing, employment and other resources in your community.

GET STARTED

Start Your Recovery Today